Traversal of multilayered corneal epithelia by cytotoxic pseudomonas aeruginosa requires the phospholipase domain of ExoU

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 1, 2012, Pages 448-453

  Ramirez, Julio C ^a   Fleiszig, Suzanne M J ^a,b   Sullivan, Aaron B ^a   Tam, Connie ^a   Borazjani, Roya ^c,d   Evans, David J ^a,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ALCON RESEARCH LTD   (United States)

^d New Technologies and Research and Development   (United States)

^e TOURO UNIVERSITY CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; EXOU PROTEIN; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; PHOSPHOLIPASE; PSEUDOMONAS EXOPROTEIN A PROTEIN, PSEUDOMONAS AERUGINOSA;

ARTICLE; BACTERIUM MUTANT; CONTROLLED STUDY; CORNEA EPITHELIUM; CYTOTOXICITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; CELL CULTURE; IMPEDANCE; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE;

BACTERIAL PROTEINS; CELLS, CULTURED; ELECTRIC IMPEDANCE; EPITHELIUM, CORNEAL; HUMANS; PHOSPHOLIPASES; PROTEIN STRUCTURE, TERTIARY; PSEUDOMONAS AERUGINOSA;

EID: 84859234215     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-8999     Document Type: Article

References (44)

1. Ibrahim YW, Boase DL, Cree IA. Epidemiological characteristics, predisposing factors and microbiological profiles of infectious corneal ulcers: the Portsmouth corneal ulcer study. Br J Ophthalmol. 2009;93(10):1319-1324.
2. Green M, Apel A, Stapleton F. A longitudinal study of trends in keratitis in Australia. Cornea. 2008;27(1):33-39.
3. Shah A, Sachdev A, Coggon D, Hossain P. Geographic variations in microbial keratitis: an analysis of the peer-reviewed literature. Br J Ophthalmol. 2011;95(6):762-767.
4. Fleiszig SM, Zaidi TS, Preston MJ, et al. Relationship between cytotoxicity and corneal epithelial cell invasion by clinical isolates of Pseudomonas aeruginosa. Infect Immun. 1996;64(6):2288-2294.
5. Fleiszig SM, Wiener-Kronish JP, Miyazaki H, et al. Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S. Infect Immun. 1997;65(2):579-586.
6. Finck-Barbancon V, Goranson J, Zhu L, et al. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Mol Microbiol. 1997;25(3):547-557.
7. Sato H, Frank DW, Hillard CJ, et al. The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin. ExoU. EMBO J. 2003;22(12):2959-2969.
8. Sato H, Feix JB, Hillard CJ, Frank DW. Characterization of phospholipase activity of the Pseudomonas aeruginosa type III cytotoxin. ExoU. J Bacteriol. 2005;187(3):1192-1195.
9. Zolfaghar I, Evans DJ, Ronaghi R, Fleiszig SM. Type III secretiondependent modulation of innate immunity as one of multiple factors regulated by Pseudomonas aeruginosa RetS. Infect Immun. 2006;74(7):3880-3889.
10. Tam C, Lewis SE, Li WY, et al. Mutation of the phospholipase catalytic domain of the Pseudomonas aeruginosa cytotoxin ExoU abolishes colonization promoting activity and reduces corneal disease severity. Exp Eye Res. 2007;85(6):799-805.
11. Shaver CM, Hauser AR. Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung. Infect Immun. 2004;72(12):6969-6977.
12. Alarcon I, Evans DJ, Fleiszig SM. The role of twitching motility in Pseudomonas aeruginosa exit from and translocation of corneal epithelial cells. Invest Ophthalmol Vis Sci. 2009;50(5):2237-2244.
13. Alarcon I, Kwan L, Yu C, et al. Role of the corneal epithelial basement membrane in ocular defense against Pseudomonas aeruginosa. Infect Immun. 2009;77(8):3264-3271.
14. Azghani AO, Gray LD, Johnson AR. A bacterial protease perturbs the paracellular barrier function of transporting epithelial monolayers in culture. Infect Immun. 1993;61(6):2681-2686.
15. Azghani AO. Pseudomonas aeruginosa and epithelial permeability: role of virulence factors elastase and exotoxin A. Am J Respir Cell Mol Biol. 1996;15(1):132-140.
16. Soong G, Parker D, Magargee M, Prince AS. The type III toxins of Pseudomonas aeruginosa disrupt epithelial barrier function. J Bacteriol. 2008;190(8):2814-2821.
17. Hirakata Y, Srikumar R, Poole K, et al. Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa. J Exp Med. 2002;196(1):109-118.
18. Kwong MS, Evans DJ, Ni M, et al. Human tear fluid protects against Pseudomonas aeruginosa keratitis in a murine experimental model. Infect Immun. 2007;75(5):2325-2332.
19. Miyata S, Casey M, Frank DW, et al. Use of the Galleria mellonella caterpillar as a model host to study the role of the type III secretion system in Pseudomonas aeruginosa pathogenesis. Infect Immun. 2003;71(5):2404-2413.
20. Van Alst NE, Wellington M, Clark VL, et al. Nitrite reductase NirS is required for type III secretion system expression and virulence in the human monocyte cell line THP-1 by Pseudomonas aeruginosa. Infect Immun. 2009;77(10):4446-4454.
21. Liberati NT, Urbach JM, Miyata S, et al. An ordered, nonredundant library of Pseudomonas aeruginosa strain PA14 transposon insertion mutants. Proc Natl Acad Sci U S A. 2006;103(8):2833-2838.
22. Vallis AJ, Finck-Barbancon V, Yahr TL, Frank DW. Biological effects of Pseudomonas aeruginosa type III-secreted proteins on CHO cells. Infect Immun. 1999;67(4):2040-2944.
23. McNamara NA, Van R, Tuchin OS, Fleiszig SM. Ocular surface epithelia express mRNA for human beta defensin-2. Exp Eye Res. 1999;69(5):483-490.
24. Augustin DK, Heimer SR, Tam C, et al. Role of defensins in corneal epithelial barrier function against Pseudomonas aeruginosa traversal. Infect Immun. 2011;79(2):595-605.
25. Fleiszig SM, Evans DJ, Do N, et al. Epithelial cell polarity affects susceptibility to Pseudomonas aeruginosa invasion and cytotoxicity. Infect Immun. 1997;65(7):2861-2867.
26. Lee A, Chow D, Haus B, et al. Airway epithelial tight junctions and binding and cytotoxicity of Pseudomonas aeruginosa. Am J Physiol. 1999;277(1 Pt 1):L204-L217.
27. Saliba AM, Nascimento DO, Silva MC, et al. Eicosanoid-mediated proinflammatory activity of Pseudomonas aeruginosa ExoU. Cell Microbiol. 2005;7(12):1811-1822.
28. Plotkowski MC, Brandao BA, de Assis MC, et al. Lipid body mobilization in the ExoU-induced release of inflammatory mediators by airway epithelial cells. Microb Pathog. 2008;45(1):30-37.
29. Cuzick A, Stirling FR, Lindsay SL, Evans TJ. The type III pseudomonal exotoxin U activates the c-Jun NH2-terminal kinase pathway and increases human epithelial interleukin-8 production. Infect Immun. 2006;74(7):4104-4113.
30. Coyne CB, Vanhook MK, Gambling TM, et al. Regulation of airway tight junctions by proinflammatory cytokines. Mol Biol Cell. 2002; 13(9):3218-3234.
31. Barbieri JT, Sun J. Pseudomonas aeruginosa ExoS and ExoT. Rev Physiol Biochem Pharmacol. 2004;152:79-92.
32. Yahr TL, Vallis AJ, Hancock MK, et al. ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system. Proc Natl Acad Sci U S A. 1998;95(23):13899-13904.
33. Deng Q, Sun J, Barbieri JT. Uncoupling Crk signal transduction by Pseudomonas exoenzyme T. J Biol Chem. 2005;280(43):35953-35960.
34. Cowell BA, Chen DY, Frank DW, et al. ExoT of cytotoxic Pseudomonas aeruginosa prevents uptake by corneal epithelial cells. Infect Immun. 2000;68(1):403-406.
35. Garrity-Ryan L, Kazmierczak B, Kowal R, et al. The arginine finger domain of ExoT contributes to actin cytoskeleton disruption and inhibition of internalization of Pseudomonas aeruginosa by epithelial cells and macrophages. Infect Immun. 2000;68(12):7100-7113.
36. Lomholt JA, Poulsen K, Kilian M. Epidemic population structure of Pseudomonas aeruginosa: evidence for a clone that is pathogenic to the eye and that has a distinct combination of virulence factors. Infect Immun. 2001;69(10):6284-6295.
37. Stewart RM, Wiehlmann L, Ashelford KE, et al. Genetic characterization indicates that a specific subpopulation of Pseudomonas aeruginosa is associated with keratitis infections. J Clin Microbiol. 2011;49(3):993-1003.
38. Feltman H, Schulert G, Khan S, et al. Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa. Microbiology. 2001;147(Pt 10):2659-2669.
39. Lakkis C, Fleiszig SM. Resistance of Pseudomonas aeruginosa isolates to hydrogel contact lens disinfection correlates with cytotoxic activity. J Clin Microbiol. 2001;39(4):1477-1486.
40. Fleiszig SM, Lee EJ, Wu C, et al. Cytotoxic strains of Pseudomonas aeruginosa can damage the intact corneal surface in vitro. Clao J. 1998;24(1):41-47.
41. Lee EJ, Cowell BA, Evans DJ, Fleiszig SM. Contribution of ExsAregulated factors to corneal infection by cytotoxic and invasive Pseudomonas aeruginosa in a murine scarification model. Invest Ophthalmol Vis Sci. 2003;44(9):3892-3898.
42. Alarcon I, Tam C, Mun JJ, et al. Factors impacting corneal epithelial barrier function against Pseudomonas aeruginosa traversal. Invest Ophthalmol Vis Sci. 2011;52(3):1368-1377.
43. Tam C, Ledue J, Mun JJ, et al. 3D quantitative imaging of unprocessed live tissue reveals epithelial defense against bacterial adhesion and subsequent traversal requires MyD88. PLoS One. 2011; 6(8):e24008.
44. Mun JJ, Tam C, Kowbel D, et al. Clearance of Pseudomonas aeruginosa from a healthy ocular surface involves surfactant protein D and is compromised by bacterial elastase in a murine null-infection model. Infect Immun. 2009;77(6):2392-2398.